| Name |  |  | 
   
  | Last NAV | 34.12 | 54.09 | 
  | Date of Valuation | 2025/10/30 | 2025/10/30 | 
  | Sharpe Ratio | 0.80 | N/A | 
  | 3-Year Risk Return Ratio | 1.00 | 1.09 | 
  | Cumulative Performance (%) | 
  |  | +16.49% | +16.35% | 
  |  | +25.03% | +33.03% | 
  |  | +63.41% | +43.17% | 
  |  | +79.67% | +37.81% | 
  |  | +12.37% | +17.29% | 
  |  | -0.61% | -17.36% | 
  |  | -3.30% | +33.53% | 
  |  | N/A | +440.90% | 
  | Calendar Year Performance (%) | 
  |  | +12.37% | +17.29% | 
  |  | -32.88% | -12.51% | 
  |  | -0.61% | -17.36% | 
  |  | +47.00% | +27.52% | 
  |  | -3.30% | +33.53% | 
  | 3-Year Annualised Volatility | 22.67% | 17.81% | 
   
  | Funds House | Baring Asset Management (Asia) Limited | Franklin Templeton Investments (Asia) Ltd | 
  | Portfolio Manager | SooHai Lim & Eunice Hong | Evan McCulloch & Wendy Lam & Akiva Felt | 
  | Funds Type | Equity Funds | Equity Funds | 
  | Funds Size | USD 32000000 | USD 1590000000 | 
  | Base Currency | USD | USD | 
  | Sector | General | Biotechnology | 
  | Geographic Allocation | Korea | US | 
   
  | Top Holdings | 
  |  | SK hynix (8.42%) | AMGEN INC (8.16%) | 
  |  | Samsung Electronics (7.31%) | REGENERON PHARMACEUTICALS INC (7.13%) | 
  |  | Hyundai Motor (5.99%) | VERTEX PHARMACEUTICALS INC (5.83%) | 
  |  | KB Financial Group (5.26%) | INSMED INC (3.82%) | 
  |  | Kia Corp. (3.47%) | GILEAD SCIENCES INC (3.69%) | 
  |  | LG CHEM LTD (3.57%) | ASTRAZENECA PLC (2.92%) | 
  |  | SAMSUNG FIRE AND MARINE INSURANCE CO LTD (3.01%) | INTRA-CELLULAR THERAPIES INC  (2.84%) | 
  |  | SAMSUNG BIOLOGICS (3.92%) | BIOGEN INC (2.74%) | 
  |  | Shinhan Financial Group (4.33%) | MERUS NV (2.73%) | 
  |  | LG ENERGY SOLUTION LTD (3.47%) | ARGENX SE (2.68%) | 
   
  | Minimum Initial Investment | USD 1000 | USD 1000 | 
  | Initial Sales Fee | Up to 5% of the net asset value per unit. | Class A: Up to 5.00%. Class B: Nil | 
  | Switching Fee | Not applicable | Class A: 1.00%. Class B:  Nil | 
  | Maintenance Fee | Custodian fee (Trustee fee):0.025%, subject to monthly minimum fee of £6000.Administration fee:0.275%, subject to monthly minimum fee of £12000.Transaction charge:£50 per security transaction | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%.  Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum.  Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. | 
  | Redemption Fee | Nil | Class A: Nil. Class B: Up to 4.00% | 
   
  | Launch Date | 1992/11/04 | 2000/04/03 | 
  | End of Financial Year | 30/04 | 30/06 | 
  | Country of Registry | Ireland | Luxembourg | 
   
  | Other Relevant Information |  |  | 
  |  |  |